Clinical Trials

Cognito Therapeutics and Providence Health Plan will collaborate on a phase 3 study of a noninvasive therapy for patients with mild cognitive impairment, according to a release.

One out of three registered randomized controlled trials on connective tissue diseases are never completed or published, representing a “waste of energy or resources” that may skew meta-analyses, according to researchers.

Clinical trial sponsors said they have adopted new methods and decentralized procedures that may increase diversity and inclusion in future trials.

Quviviq 25 mg and 50 mg enhanced sleep among patients with insomnia disorder, according to results of two randomized, double-blind, placebo-controlled, phase 3 trials published in The Lancet Neurology.

Prolonged exposure had a slight advantage over cognitive processing therapy for PTSD symptoms, although both treatments offered meaningful improvements, according to results of a randomized clinical trial published in JAMA Network Open.

Clinical-stage biotech developer ABL Bio Inc. announced it will collaborate and enter a worldwide license agreement with Sanofi to develop and commercialize a treatment for Parkinson’s disease and other potential indications.

Pacific Neuroscience Institute announced the start of a new clinical trial to assess the safety and efficacy of psilocybin to treat major depressive disorder and has begun participant enrollment, according to a company release.

The FDA has granted an investigational drug designation to PCN-101 ahead of a clinical study to be conducted by atai Life Sciences, according to a company release.

Neuroimaging company Imeka announced it has partnered with Atara Biotherapeutics Inc. to use Imeka’s novel biomarker technology in a phase 2 clinical study of individuals with progressive forms of MS.

As the United States enters an era of precision medicine in oncology, it is important that the racial disparities that currently exist in breast cancer care do not leave certain populations behind, according to an expert.